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http://www.biomedcentral.com/1471-2415/13/22RESEARCH ARTICLE Open AccessLate-onset secondary pigmentary glaucoma
following foldable intraocular lenses implantation
in the ciliary sulcus: a long-term follow-up study
Shirley HL Chang1,2, Wei-Chi Wu1,2 and Shiu-Chen Wu1,2*Abstract
Background: To review the long-term outcomes of eyes with secondary pigmentary glaucoma associated with the
implantation of foldable intraocular lenses (IOL) in the ciliary sulcus.
Methods: The study retrospectively reviewed a series of cases who developed secondary pigmentary glaucoma
after cataract operations. Data were collected from cases that were referred between 2002 and 2011.
Results: Ten eyes of 10 patients who developed secondary pigmentary glaucoma after foldable IOLs implantation
in the sulcus were included in this study.
Intraocular pressure (IOP) elevation was present in 2 eyes (20%) within the first 2 weeks following the initial cataract
operation. The onset of glaucoma was delayed in the other 8 eyes (80%); the average onset time in these eyes was
21.9 ± 17.1 months after the initial cataract operation. Six eyes (60%) received surgical treatment because of large
fluctuations and poor control of IOPs. Only 3 eyes (30%) achieved final visual acuities better than 20/40.
Conclusion: Secondary pigmentary glaucoma accompanying the implantation of a foldable IOL in the ciliary sulcus
may present as acute IOP elevation during the early postoperative period or, more commonly, late onset of IOP
elevation accompanied by advanced glaucomatous optic nerve damage. Despite treatment, the visual prognosis for
these patients can be poor. Placing a foldable IOL in the ciliary sulcus could pose a threat to the vision of the
patients and long-term follow-up of IOP in these patients is necessary.
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Secondary pigmentary glaucoma has been reported in
patients who have undergone posterior chamber intraoc-
ular lens (IOL) implantation during cataract surgery, es-
pecially when the IOL was implanted in the ciliary
sulcus following rupture of the posterior capsule [1-12].
Secondary pigmentary glaucoma can be identified via
pigment deposit on the corneal endothelium and IOL,
and by heavy pigmentation of the trabecular meshwork.
Mechanical rubbing between the foldable IOL and the
posterior region of the iris following the placement of
the IOL in the sulcus can contribute to the release of
pigments [1-12]. This release may present as either* Correspondence: shiuchen@adm.cgmh.org.tw
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reproduction in any medium, provided the orpigment dispersion syndrome accompanied by normal
intraocular pressure (IOP) or pigmentary glaucoma ac-
companied by IOP elevation, glaucomatous optic nerve
neuropathy and visual field loss. Because the implant-
ation of a foldable IOL has become a popular choice
for lens implantation after phacoemulsification, a signifi-
cant number of foldable IOLs may have been either
inadvertently or intentionally placed in the ciliary sulci
of cataract patients following the rupture of the poster-
ior capsule.
Most reports regarding the development of secondary
pigmentary glaucoma following the implantation of a
foldable IOL in the sulcus are either case reports or
small case series [3-5,7,10-12]. Only two studies involve
a larger number of cases, one of 20 and the other of 30
subjects [8,9]. However, the follow-up periods over
which the patients in these studies were monitored areLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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aforementioned prior studies are Caucasian. To address
these issues, the present study investigates the pattern of
IOP elevation and secondary pigmentary glaucoma fol-
lowing the implantation of foldable IOLs in the ciliary
sulci of a group of Chinese patients with at least
20 months of follow-up. Both acute-onset and late-onset
pigmentary glaucoma following the placement of an IOL
in the ciliary sulcus are examined.
Methods
The present study was designed as a retrospective study.
The study reviewed a series of consecutive cases that
were referred to the glaucoma clinics at the Department
of Ophthalmology at Chang Gung Memorial Hospital
in Taoyuan, Taiwan following the development of sec-
ondary IOP elevation after the patients underwent cata-
ract operations. Data were collected from cases that
were referred between 2002 and 2011. The Chang Gung
Medical Foundation Institution Review Board approved
the study.
Cases with secondary IOP elevation following
phacoemulsification and foldable IOL implantation in
which at least one haptic was placed in the ciliary sulcus
were included in the study. All of these cases had open
angles and heavy pigmentation on the trabecular mesh-
work in gonioscopy. Patients who had any history of
uveitis, pigment dispersion syndrome, or glaucoma
prior to undergoing the cataract operations were ex-
cluded. The cornea, iris, lens, and angle status of the
fellow eyes were all evaluated by slit-lamp examination
and gonioscopy to rule out the diagnosis of primary
pigmentary glaucoma. In patients whose gonioscopy
showed peripheral anterior synechiae of more than 90
degrees, or who were followed up for fewer than
6 months were also excluded. The main outcome mea-
sures were the onset of pigmentary glaucoma and the
visual results of these cases following medical and sur-
gical glaucoma treatment. External eye photography
was performed to record the position of the IOL. Ultra-
sound biomicroscopy (UBM) was performed to estab-
lish the IOL position in the sulcus and to identify any
possible contact between the IOL and the iris.
Gonioscopy was performed to document both the sta-
tus and the pigmentation of the angle. Visual field test-
ing was performed to document visual field defects
after the onset of glaucoma.
The patients’ records were reviewed to collect the fol-
lowing data: the initial IOPs (defined as IOP at referral)
and final IOPs (defined as IOP at last visit); the initial
visual acuity (VA) at referral and the final VA at the last
visit; any visual field defects; the axial length; the pres-
ence or absence of an IOP elevation more than
21 mmHg during the early post-operative period; timeof IOP elevation (defined as the time that elapsed be-
tween the initial cataract operation and the onset of
chronic IOP elevation more than 21 mmHg); the follow-
up period (defined as the time from the referral visit to
the last visit); the type of IOL that was used; the pres-
ence or absence of vitreous incarceration around the
IOL; the decentration of the IOL; the presence of
chronic iridocyclitis; the method(s) of IOP control; and
the visual outcome. Numerical variables are presented as
the means and standard deviations (mean ± SD).
Results
A total of 10 eyes of 10 patients were enrolled in this
study. All of included eyes were referral cases from other
clinics or hospitals. All of the included cases were
Chinese. The mean age of the patients was 59.6 ±
10.7 years (range: 39–75 years). Six patients were men,
and four patients were women.
Two different types of IOLs were used in the patients:
9(90%) one-piece foldable IOLs (Acrysof SA 60AT or
SA30AT; Alcon, Fort Worth, Texas, USA), and 1 (10%)
silicone IOL (CeeOn 911A, Pharmacia and Upjohn,
Kalamazoo, Michigan, USA). At least one haptic of the
IOL that was implanted in each eye was placed in the
ciliary sulcus. The average time that elapsed between the
implantation of the IOL and the onset of IOP elevation
was 21.9 ± 17.0 months for all of the cases, and it ranged
from 0.5 to 48 months. IOP elevation more than
21 mmHg within the 2 weeks after the initial cataract
operation that constituted the early post-operative
period was only observed in 2 cases (20%). One of the
cases had persistent IOP elevation. The IOP of the other
patient was soon put under control by anti-glaucoma
medications, and he did not attend follow-up appoint-
ments until he experienced a second IOP elevation
4 months later. The other 8 eyes (80%) had delayed glau-
coma onset, with the time between the initial cataract
operation and the onset of glaucoma ranging between 4
and 48 months. The average period of time between the
implantation of the IOL and the onset of glaucoma
symptoms in these late-onset cases was 27 ± 15.3 months.
Heavy pigmentation was observed in the angles of all of
the diseased eyes (Figure 1). Pigment deposit was also
observed on the corneal endothelium and the IOLs. Vit-
reous incarceration around the implanted IOL was
found during the examinations of 3 of the 10 eyes (30%),
and lens subluxation was noted in 2 eyes (20%). IOL was
noted to have different positions at different times dur-
ing the follow-up period in 1 eye (10%) (Figure 2).
Chronic recurrent iridocyclitis was observed in 6 of the
eyes (60%) during the follow-up period. UBM showed
iris-IOL chafing in all of the cases included in the study
(Figure 3). The demographic and clinical characteristics
of the patients are shown in Table 1.
Figure 1 Pigmentation of the angle structure after the
implantation of a foldable intraocular lens (IOL) in the ciliary
sulcus of one patient. Compared with the angle of the fellow eye
(OS), the angle in the eye in which the IOL had been implanted in
the sulcus (OD) had much heavier pigmentation.
Figure 3 Contact between the intraocular lens (IOL) and the iris
demonstrated via ultrasound biomicroscopy (UBM). UBM
revealed that the optic of the IOL had direct contact with iris in this
case (arrows), in which the IOL tilted because one haptic had been
placed in the capsular bag and the other haptic had been placed in
the sulcus.
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21 mmHg at the onset of glaucoma. The mean initial
IOP was 35.1 ± 7.6 mmHg (range: 25-51 mmHg). The
average range of IOP fluctuation during different visits
in these patients was 12.1 ± 7.0 mmHg, with a range
from 4 to 21 mmHg. Four eyes (40%) were controlled
with medication(s) alone, and, due to large IOP fluctua-
tions (13 ± 5.2 mmHg) and poor control of the IOPs of
the 6 remaining eyes (60%), these patients were treated
with additional surgical procedures, which included re-
placing the foldable IOL with a polymethylmethacrylate
(PMMA) IOL (3 cases), anterior vitrectomies, or ex-
change of IOL combined with trabeculectomies that
were enhanced with the use of mitomycin C (3 cases).Figure 2 Different intraocular lens (IOL) positions examined on differ
IOL had shifted between the earlier and later examinations. The locations o
changed between the 2 examination dates (A and B). The shifting position
chronic inflammation of the eye.After the various treatments, 2 eyes (20%) maintained
their initial VAs, 3 eyes (30%) had improved vision, and
5 eyes (50%) had poorer VAs compared with their initial
VAs. Only 3 eyes (30%) achieved final VAs better than
20/40. The mean follow-up period was 46.3 ±
21.3 months (range: 20–76 months). The treatment out-
comes and the visual prognoses of the patients are
shown in Table 2.
The phakic status of the fellow eyes included 5 phakic
eyes and 5 pseudophakic eyes. The gonioscopic finding
of these fellow eyes all showed an open angle with lightent dates following placement in the sulcus. The position of the
f both the margin of the IOL (arrows) and the IOL haptic (asterisk) had
of the IOL could have caused the dispersion of iris pigment and
Table 1 Demographic and clinical characteristics of 10
patients
Eye (R/L) (no.) 5/5
Sex (M/F)(no.) 6/4
Age (year)
Average 59.6 ± 10.7
Range 39-75
Type of IOL(no.)
One-piece foldable IOL 9
Silicon IOL 1
IOL subluxation (Yes/No)(no.) 2/8
Chronic iridocyclitis (Yes/No)(no.) 6/4
Time of IOP elevation (months)(no.)*
< 2 weeks 2
2 weeks-12 months 2
12-24 months 2
>24 months 4
Vitreous incarceration (Yes/No)(no.) 3/7
F female, IOP intraocular pressure, IOL intraocular lens, M male, m months, no.
number, R right eye, L left eye.
*following cataract surgery in which an IOL was implanted in the ciliary sulcus.
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3.3 mmHg. None of these fellow eyes showed signs of
glaucoma.
Discussion
Our study has shown that secondary pigmentary glau-
coma accompanying the implantation of a foldable IOL
in the ciliary sulcus may present as an acute IOP eleva-
tion during the early postoperative period in a small per-
centage of patients (20%). Late-onset IOP elevation with
glaucomatous optic nerve damage was observed in the
majority of the cases (80%). Most previous articles aboutTable 2 Treatment outcomes and visual prognoses of patient
of an intraocular lens in the ciliary sulcus




Initial VA Final VA
1 33 12 FC 20/222
2 39 8 20/400 FC
3 32 19 20/32 20/32
4 31 10 20/100 20/50
5 51 12 20/32 20/200
6 34 13 20/22 20/63
7 35 12 20/22 20/32
8 45 14 20/400 20/100
9 26 16 FC FC
10 25 16 20/63 20/285
IOP intraocular pressure, VA visual acuity, Initial IOP IOP at referral, Final IOP IOP in t
FC fingers count, F/U follow-up, HM detects hand motion, IOL intraocular lens, m mthe development of secondary pigmentary glaucoma fol-
lowing the implantation of an IOL in the ciliary sulcus
reported early onset of post-surgical IOP elevation
[7,11,12]. Some cases may have had normal IOPs or may
have presented with transient IOP elevations during the
initial postoperative period and were soon controlled by
anti-glaucoma medication. These cases could present as
acute IOP elevation with chronic glaucomatous optic
nerve damage at a later date. At later stages in our study,
large IOP fluctuations even with medical control were
noted in 60% of the cases. This observation may be re-
lated to changes in the position of the IOL within the
sulcus, and surgical interventions are necessary to con-
trol the IOPs in the patients. Cases with chronic IOP
elevation that is not responsive to treatment with anti-
glaucoma medications may require the replacement of
the IOL, and/or a trabeculectomy with mitomycin C to
control the IOP. Anterior vitrectomy might be needed
to release the vitreous incarceration of the IOL during
the exchange of IOL. Despite the use of various treat-
ments, the visual prognoses for these patients could be
poor in an advanced stage of glaucoma. Therefore, the
implantation of a foldable IOL in the ciliary sulcus may
pose a risk of developing late-onset pigmentary glau-
coma, and performing this procedure after the rupture
of the posterior capsule during a cataract surgery should
be reconsidered.
Two previous articles [13,14] that support the use of a
single-piece acrylic IOL in the sulcus have been pub-
lished. However, other studies [7,9,15,16] have reported
that this kind of IOL may induce surgical complications
ranging from iris chafing and uveitis-glaucoma-hyphema
(UGH) syndrome to vitreous hemorrhage. Uy and Chan
[8] found evidence of associations between the implant-
ation of sulcus-fixated, single-piece hydrophobic acrylic
intraocular lenses and pigment release and secondarys with pigmentary glaucoma following the implantation
Management F/U period
(months)
IOL exchange + anterior vitrectomy 29
Medical treatment 41
Medical treatment 47
IOL exchange + anteriorvitrectomy 47
IOL exchange + anterior vitrectomy + trabeculectomy 72
IOL exchange 20
IOL exchange + trabeculectomy 72
IOL exchange + trabeculectomy 10
Medical treatment 49
Medical treatment 76
he last visit, Initial VA VA at referral, Final VA VA in the last visit;
onth, mmHg millimeter of mercury, no. number.
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veloped pigment release and 3 eyes (15%) developed sec-
ondary glaucoma. Chang et al. [9] report the largest case
series (30 cases) published to date of patients with
chronic complications resulting from sulcal placement
of single-piece acrylic IOLs. In addition to pigment dis-
persion syndrome, they found evidence that complica-
tions such as recurrent iridocyclitis with secondary IOP
elevation, intraocular hemorrhage, cystoid macular
edema (CME), and lens decentration with symptomatic
edge glare can occur [9]. However, as the average follow-
up duration in Uy and Chan’s study [8] was only 17.2 ±
9.4 months, the incidence could be higher if those pa-
tients had been followed up over a longer period.
The vision of the patients in our study seems to be
much worse than that of patients in previous studies. Only
3 eyes (30%) achieved final VAs of better than 20/40.
Chang et al. [9] reported that the mean corrected distance
visual acuities of the patients in their study improved post-
operatively, resulting in the majority of eyes eventually
attaining an acuity of 20/20. Uy and Chan [8] described
postoperative best-corrected VAs of 20/40 or better in all
of the eyes with pigment release and secondary glaucoma.
In light of these findings from other studies, we propose
some hypotheses regarding the poor vision of our patients.
First, all of our patients were referral cases, and 6 of the
eyes (60%) presented with visual acuities that were poorer
than 20/40 at the time of referral. The high IOP at referral,
corneal edema, lens subluxation and advanced glaucomat-
ous optic nerve damage could be the causes of poor VA at
referral. The IOPs of these patients may have fluctuated
before they became symptomatic with uncontrolled IOP
elevation, and this in turn could have led to advanced
glaucomatous optic neuropathy prior to referral. Two eyes
had lens subluxation and 6 eyes had chronic iridocyclitis.
Finally, fluctuations of the IOPs in these patients were fre-
quently noted despite medical and surgical interventions.
All of these factors can lead to poor visual prognoses of
our patients.
IOP elevation in the patients with sulcal foldable IOL
implantation may be resulted from multiple mecha-
nisms, including post-operative inflammation, chronic
iridocyclitis, vitreous incarceration and pigment disper-
sion. Early IOP elevation might mainly result from the
inflammation associated with the improper management
of surgical complications such as vitreous incarceration.
At the later stage, IOP elevation in the patients with
sulcal foldable IOL implantation may be resulted from
chronic iridocyclitis and pigment dispersion. Iris chafing
by the IOL can arise because of the closer contact be-
tween the IOL and the iris that results from the sulcal
placement of the IOL [2-5,7-12]. In addition, the flexible
haptics of a foldable IOL facilitate the rubbing-induced
detachment of iris pigments. Finally, the IOL can still bemoving around freely as a result of the foldable IOL hav-
ing a relatively smaller diameter than that of the sulcus
(Figure 2). This could subsequently induce a “pigment
storm” resulting in pigment accumulation in the tra-
becular meshwork that might further compromise the
trabecular outflow and give rise to glaucoma. The most
common histopathologic finding among the patients in
the study by Chang et al. [9] was that of pigment gran-
ules on the anterior surface of the IOL, with the greatest
accumulation occurring on the haptic of the IOL as well
as the peripheral optic and the haptic–optic junction.
These findings are consistent with the notion of poster-
ior iris chafing caused by the optic and the relatively
thick flexible haptics, all of which have squared edges
and unpolished side walls. In one study of an experimen-
tal pigmentary glaucoma [17] model, researchers dem-
onstrated an acute and substantial lowering of the
outflow facility of the trabecular meshwork after pig-
ment particles had been infused into the anterior cham-
ber. During an early stage of the disease, pigment can be
phagocytosed by trabecular meshwork cells or migrated
away via trabecular endothelial cells with the outflow fa-
cility returning to normal [17]. However, in advanced
pigmentary glaucoma, the trabecular tissue becomes
overwhelmed and there is a loss of endothelial cell mi-
gration accompanied by collapse of the trabecular beams
and subsequent sclerosis of the tissue [18,19]. This find-
ing is compatible with the clinical course of the late-
onset of IOP elevation that was observed in our study.
To avoid the complication of secondary pigmentary glau-
coma following cataract surgery with vitreous loss, manage-
ment of the herniated vitreous body using a vitrectomy and
choosing and implanting IOL properly are very important.
In these cases, the implantation of either a PMMA poster-
ior chamber IOL in sulcus or an anterior chamber IOL can
be performed following the vitrectomy. Fixating 3-piece
acrylic IOL with suture or capturing the optic within a
well-centered capsulorhexisis is another option [9].
As far as we are aware, the present study represents
the largest case series to examine pigmentary glaucoma
following the implantation of foldable IOLs in the ciliary
sulci of an Asian study population. The average follow-
up of the patients is over 3 years. However, the study is
still limited by its retrospective nature, variable follow-
up periods, and small number of cases. In addition, no
control group was available. Thus, in view of the afore-
mentioned limitations, cause and effect could not be
established in this study. Improper management in cases
in which there was vitreous loss could also contribute
the pigment dispersion in some of our cases. More data
are needed to explore both the incidence of secondary
pigmentary glaucoma following the implantation of a
foldable IOL in the sulcus and the causal relationship
between such a procedure and its complications.
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This study has shown that secondary pigmentary glau-
coma following the implantation of a foldable IOL in the
ciliary sulcus may present as an acute IOP elevation dur-
ing the early postoperative period. Or more commonly, it
can present as late-onset chronic IOP elevation accom-
panied by large IOP fluctuations and glaucomatous optic
nerve damage during a long-term follow-up period. Surgi-
cal interventions are usually needed in these cases. Late-
onset of glaucoma symptoms and IOP fluctuation may
result in poor visual prognosis despite medical or surgical
management. Implantation of a foldable IOL in the ciliary
sulcus is therefore not recommended. Because late-onset
pressure rise may occur in these patients, long-term follow
up for these patients is necessary if such a procedure is to
be performed.
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